The Federal Reserve’s dual mandate will be covered this week with the release of the January jobs report and the consumer price index. Plus, earnings from Cisco Systems, Applied Materials, Arista, and ...

A trifecta of key economic releases and earnings from several noteworthy firms will be of interest to market watchers this ...

Arkansas-based retailer, which recently topped a $1 trillion market capitalization, employs roughly 35,000 pharmacy ...

Regeneron beat Q4 earnings and sales estimates as Dupixent gains offset weaker Eylea sales. The drugmaker also outlined 2026 ...

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) announced Monday it has entered into an at-the-market (ATM) sales agreement with Virtu Americas LLC. Under the terms of the agreement, NovaBay may offer and ...

Hundreds of new manufacturing jobs are coming to Wilson, Gov. John Stein announced Friday, as Johnson & Johnson has decided to build a multibillion-dollar expansion onto their existing operations in ...

Specialty medications, which can cost between $10,000 and upward of $5 million, now account for 52% of U.S. pharmaceutical sales, according to a Dec. 30 report from the Healthcare Distribution ...

These two healthcare stocks are top names to invest in, but they haven't both been doing well of late. Eli Lilly has generated $25 billion in revenue from its fast-growing GLP-1 drugs this year. Novo ...

Editor’s note: This story has been updated to include a comment from Intercept Pharmaceuticals. A pharmaceutical company headquartered in New Jersey is shrinking its workforce one month after pulling ...

6-month commercial pilot demonstrated increasing demand among prescribers Expansion plan includes doubling the number of sales reps, a new GoodRx partnership, and enhanced digital marketing campaign ...

The pharmaceutical company Eli Lilly is planning to invest more than $6 billion in a new manufacturing facility that is expected to bring 3,450 manufacturing and construction jobs. The facility is ...

Secretary of Health and Human Services Robert F. Kennedy Jr. wants the United States to limit pharmaceutical ads to consumers, citing concerns that advertising leads to increased use of prescription ...